ResMed Inc (ASX:RMD)
A$ 28.61 +0.040 (+0.14%) Market Cap: 42.90 Bil Enterprise Value: 41.72 Bil PE Ratio: 19.17 PB Ratio: 4.44 GF Score: 98/100

Resmed Inc at Macquarie Australia Conference (Virtual) Transcript

May 4, 2021 / 10:45 PM GMT
Release Date Price: A$25.29 (+1.12%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RMD.N - Resmed Inc
Resmed Inc at Macquarie Australia Conference (Virtual)
May 04, 2021 / 10:45PM GMT

=====================
Conference Call Participants
=====================
* David Bailey
Macquarie - Analyst
* Brett Sandercock
ResMed - CFO

=====================
Presentation
--------------------------------------------------------------------------------
David Bailey, Macquarie - Analyst [1]
--------------------------------------------------------------------------------
Good morning, everyone. Welcome to day two of the Macquarie conference. My name is David Bailey; I am part of the healthcare team here at Macquarie. Before we begin, a quick reminder -- there will be a Q&A session following Brett's presentation. If you wish to submit a question, you can do so during and after the conclusion of Brett's presentation. Moving on, it is my pleasure to introduce Brett Sandercock, CFO of ResMed. Brett, over to you.

------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot